Skip to main content
OpenTrials
Completed

NCT Number: NCT04368832

imPROving prenaTal carE During ConfinemenT

This study is a non-randomized, quasi-experimental, monocentric study comparing two prenatal monitoring modes in low-risk pregnancy: including at least one remote consultation (phone or teleconsultation) versus face-to-face adapted to confinement. The quality of care perceived by the pregnant women were evaluated according to monitoring modes set up during the COVID-19 pandemic confinement period. The women included planned to give birth at the regional academic Maternity of Nancy, France.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Maternité Régionale Universitaire de Nancy

Nancy, 54035, France

About this study

The emergency confinement measures deployed by most industrialized countries governments to limit the impact of the coronavirus disease 2019(COVID-19) pandemic resulted in rapid and unpredictable changes in methods of obstetric monitoring. International and French government recommendations called for a reorganization of mandatory monitoring, particularly for low-risk pregnancies (limit the presence of the coparent during follow-up consultations and implement remote consultations). The potential impact of this reorganization on care perception, probably increased by the context of an unprecedented economic, social and health crisis, is unpredictable. In the absence of a previous event of comparable importance, it is impossible to anticipate differences in satisfaction with antenatal management and in stress level between women exposed to the two types of monitoring. Many factors can influence the perception of care quality, such as the socio-economic environment and the level of health literacy, that is, the individual's ability to find information on health, to understand and use this information to improve his own health or develop autonomy in health care system.

The objective of this study is to determine which type of monitoring is better perceived by pregnant women, the factors associated with this perception and the links with the level of knowledge and mastery of women regarding reproductive health and digital tools.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant woman eligible for type A or A1 follow-up according to the French Health Authority "Haute Autorité de Santé" (HAS) (low-risk pregnancy)
  • Having consulted at least one practitioner (midwife or physician) during the COVID-19 national confinement period
  • Gestational age > 7 weeks of amenorrhea on 17th March 2020, at the beginning of the national confinement period in France
  • having received complete information on the organisation of this research and not opposed to participation and exploitation of her data
  • Childbirth expected in the regional academic Maternity of Nancy
  • Member of or beneficiary of a social security scheme
  • Speaking French and able to complete a self questionnaire or having the possibility of being assisted

Exclusion criteria

  • Not understanding French
  • Multiple pregnancy
  • Request for voluntary termination of pregnancy
  • Discovery or suspicion of congenital malformation
  • Under protection of justice, guardianship or trusteeship
  • Deprived of liberty by judicial or administrative decision
  • Undergoing psychiatric care under sections L. 3212-1 and L. 3213-1 of french law (hospitalization without consent).

Treatment and study plan

Remote consultation

Other

One or more consultation is conducted by phone or teleconsultation during prenatal monitoring

Primary outcomes

  1. Score of perceived quality of prenatal care

    Time frame: Through study completion, an average of 3 months, ie either at the beginning of the second or the third trimester of pregnancy, or during immediate postpartum care

    score obtained with the Quality of prenatal care questionnaire (QPCQ) as close as possible after release from containment

Secondary outcomes

  1. Level of stress during pregnancy

    Time frame: Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care

    Perceived stress measured with Perceived Stress Scale-10 (PSS-10) scale

  2. level of health and digital literacy

    Time frame: Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care

    level of health and digital literacy evaluated with Health Literacy Questionnaire (HLQ) and eHealth Literacy Questionnaire (eHLQ) questionnaire

  3. Obstetrical outcomes

    Time frame: Through study completion, an average of 6 months, ie at the end of postpartum care hospitalization

    core set of outcomes for maternity care

  4. Characteristics of medical supervision during pregnancy

    Time frame: Through study completion, an average of 6 months, ie throughout the period of pregnancy

    Number of remote, face-to-face or emergency consultations during pregnancy and requester of each consultation (patient or practitioner)

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

ImPROving prenaTal carE During ConfinemenT: Impact of Confinement on the Quality of Prenatal Care Perceived in Low-risk Pregnancy

Acronym: PROTECT

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 30, 2020
Registry last updated
Mar 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.